Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q4 2019 · 10-K
Revenue$152.78M$152.78M+8.3% vs Q4 2018 Net Income-$262.00K-$262.00KN/M vs Q4 2018 EPS Diluted$0.01$0.01−95.8% vs Q4 2018 Gross Profit$26,212,000+5.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
derived
Operating Cash Flowderived-$1,429,000N/M Free Cash Flowderived-$13,019,000N/M Margins · derivedGross margin17.2%−0.4 pt vs Q4 2018
Operating margin1.6%−4.1 pt vs Q4 2018
Net margin-0.2%−4.5 pt vs Q4 2018
ended May 26, 2019 · filed Aug 1, 2019 · 67 d after period end